These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 11499346)
21. Evaluation of the role of second-look surgery in ovarian cancer. Chambers SK; Chambers JT; Kohorn EI; Lawrence R; Schwartz PE Obstet Gynecol; 1988 Sep; 72(3 Pt 1):404-8. PubMed ID: 3405557 [TBL] [Abstract][Full Text] [Related]
22. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection. Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566 [TBL] [Abstract][Full Text] [Related]
23. Overexpression of H-Ryk in epithelial ovarian cancer: prognostic significance of receptor expression. Katso RM; Manek S; Ganjavi H; Biddolph S; Charnock MF; Bradburn M; Wells M; Ganesan TS Clin Cancer Res; 2000 Aug; 6(8):3271-81. PubMed ID: 10955813 [TBL] [Abstract][Full Text] [Related]
24. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Erzen M; Rakar S; Klancnik B; Syrjänen K Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420 [TBL] [Abstract][Full Text] [Related]
25. A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors. Ren J; Peng Z; Yang K Gynecol Oncol; 2008 Aug; 110(2):162-7. PubMed ID: 18495223 [TBL] [Abstract][Full Text] [Related]
26. [Construction and utilization of the prognostic model of serous ovarian adenocarcinoma]. Yang R; Feng J; Fang XZ; Bai F; Cheng YX; Liu C; Zhu W; Li L Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):459-63. PubMed ID: 17083811 [TBL] [Abstract][Full Text] [Related]
27. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study. Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710 [TBL] [Abstract][Full Text] [Related]
28. Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study. Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Bock JE; Glud E; Nørgaard-Pedersen B; Høgdall CK Cancer; 2003 Jul; 98(1):66-73. PubMed ID: 12833457 [TBL] [Abstract][Full Text] [Related]
29. [Treatment and prognostic factors for stage IV epithelial ovarian cancer]. Wu M; Shen K; Lang J Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):200-3. PubMed ID: 11776158 [TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for stage I ovarian carcinoma. Seidman JD; Yemelyanova AV; Khedmati F; Bidus MA; Dainty L; Boice CR; Cosin JA Int J Gynecol Pathol; 2010 Jan; 29(1):1-7. PubMed ID: 19952945 [TBL] [Abstract][Full Text] [Related]
31. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Gilks CB; Ionescu DN; Kalloger SE; Köbel M; Irving J; Clarke B; Santos J; Le N; Moravan V; Swenerton K; Hum Pathol; 2008 Aug; 39(8):1239-51. PubMed ID: 18602670 [TBL] [Abstract][Full Text] [Related]
35. [Value of prognostic factors in early stage ovarian carcinoma]. Sevelda P Zentralbl Gynakol; 1996; 118(6):326-9. PubMed ID: 8768008 [TBL] [Abstract][Full Text] [Related]
36. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063 [TBL] [Abstract][Full Text] [Related]
37. [Prognosis factors in epithelial tumors of the ovary]. Frigerio L; Ferrari A; Busci L; Pirondini A; Garsia S; Caldarella M; Pifarotti G Ann Ostet Ginecol Med Perinat; 1989; 110(6):283-9. PubMed ID: 2639615 [TBL] [Abstract][Full Text] [Related]
38. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma. Eitan R; Levine DA; Abu-Rustum N; Sonoda Y; Huh JN; Franklin CC; Stevens TA; Barakat RR; Chi DS Cancer; 2005 Apr; 103(7):1397-401. PubMed ID: 15726548 [TBL] [Abstract][Full Text] [Related]
39. Prognosis and management of borderline tumours of the ovary. Tropé C; Kaern J Curr Opin Obstet Gynecol; 1996 Feb; 8(1):12-6. PubMed ID: 8777251 [TBL] [Abstract][Full Text] [Related]
40. Is adjuvant radiotherapy in early stages (FIGO I-II) of epithelial ovarian cancer a treatment of the past? Skirnisdottir I; Nordqvist S; Sorbe B Oncol Rep; 2005 Aug; 14(2):521-9. PubMed ID: 16012740 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]